An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Peter/PetraMD intends to acquire Ketamine Wellness Centers, enhancing its footprint in the ketamine therapy market. The transaction, valued at US$1.15 Million plus existing debt, aims to maintain patient care continuity while expanding nationally. With nearly 100,000 patients treated and experience in the field, KWC is the largest ketamine provider in the US. The acquisition signals a commitment to improving access to healthcare for veterans and others in need, according to Dr. Bryan Henry. The deal is subject to due diligence and negotiation of a definitive agreement.
Positive
Acquisition value of US$1.15 Million plus existing debt indicates financial commitment.
Strategic entry into the ketamine treatment market with the largest provider.
Focus on maintaining continuity of care for existing KWC patients.
Potential expansion into the national market for improved healthcare access.
Negative
Acquisition is subject to due diligence, which could delay finalization.
Existing debt assumed may impact financial stability post-acquisition.
VANCOUVER, British Columbia--(BUSINESS WIRE)--
Peter/PetraMD, the largest online provider of hormone therapy for men and women in the United States, today announced the intent to acquire Ketamine Wellness Centers. If successful, the acquisition would represent an incredible on-ramp into the ketamine space for Peter/PetraMD. With over 20 years of experience and nearly 100,000 patients across the United States, Ketamine Wellness Centers is the largest ketamine infusion therapy provider in the US and only a handful to accept most major insurances.
Peter/PetraMD has said they intend to maintain continuity of care for current patients of Ketamine Wellness Centers while also seeking to expand into the national market with the knowledge and expertise provided by leadership. “I saw an incredible opportunity for Peter/PetraMD to truly expand the footprint and the success of ketamine treatment not only in our veteran population, but also at the national level,” said Dr. Bryan Henry, founder and a former combat veteran who is currently a successful ketamine patient. “This is a chance for more of our veteran community to have access to the care they desperately need,” Dr. Henry relays.
PeterMD will pay US$1.15 Million in tranches over twelve months plus the assumed existing debt to buy KWC subject to due diligence period, negotiation of a definitive agreement and US$100,000 non refundable deposit. “We understand telemedicine, and we understand what it is our patients want—they want to feel better, they want to get better, and they want to live better lives. This acquisition would definitely further our mission to provide affordable and equitable access to healthcare across the nation,” said Cutter Streeby, Chief Growth Officer.
About Delic Holdings Corp.
Delic (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) is a leader in new medicines and treatments for a modern world, improving access to health benefits across the country and reframing the conversation on psychedelics. The company owns and operates an umbrella of related businesses, including the largest chain of psychedelic wellness clinics in the country, Ketamine Wellness Centers; the only licensed entity by Health Canada to focus exclusively on research and development of psilocybin vaporization technology, Delic Labs; the premier psychedelic wellness event, Meet Delic; and trusted media and e-commerce platforms Reality Sandwich andDelic Radio. Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products, and better access to effective and affordable treatment options.
Forward-Looking Information and Statements
This press release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Delic's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". The forward-looking information and forward-looking statements contained herein may include, but are not limited to: information regarding the timing or terms upon which the Transaction will be completed; potential benefits of the Transaction; anticipated continued growth in the health and wellness sector (and, in particular, related to psychedelics); the ability of Delic to successfully achieve business objectives, and expectations for other economic, business, and/or competitive factors.
By identifying such information and statements in this manner, Delic is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Delic to be materially different from those expressed or implied by such information and statements. Such risks and other factors may include, but are not limited to: risks and uncertainties relating to the Transaction not closing as planned or at all or on terms and conditions set forth in the Merger Agreement; incorrect assessment of the value and potential benefits of the Transaction; direct and indirect material adverse effects from the COVID-19 pandemic; inability to obtain future financing on suitable terms; failure to obtain required regulatory and other approvals; risks inherent in the psychedelic treatment sector; changes in applicable laws and regulations; and failure to comply with applicable laws and regulations.
In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, Delic has made certain assumptions. These assumptions include, but are not limited to: assumptions as to the time required to negotiate a definite agreement and complete matters related to the Transaction; the ability to consummate the Transaction; the ability of the parties to obtain, in a timely manner, the requisite regulatory, corporate and other third party approvals and the satisfaction of other conditions to the consummation of the Transaction on the proposed terms; the potential impact of the announcement or consummation of the Transaction on relationships, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation; and the diversion of management time on the Transaction.
Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.
Although Delic believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and Delic does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to Delic or persons acting on its behalf is expressly qualified in its entirety by this notice.
